Literature DB >> 10051566

Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold.

G Beste1, F S Schmidt, T Stibora, A Skerra.   

Abstract

We demonstrate that the ligand pocket of a lipocalin from Pieris brassicae, the bilin-binding protein (BBP), can be reshaped by combinatorial protein design such that it recognizes fluorescein, an established immunological hapten. For this purpose 16 residues at the center of the binding site, which is formed by four loops on top of an eight-stranded beta-barrel, were subjected to random mutagenesis. Fluorescein-binding BBP variants were then selected from the mutant library by bacterial phage display. Three variants were identified that complex fluorescein with high affinity, exhibiting dissociation constants as low as 35.2 nM. Notably, one of these variants effects almost complete quenching of the ligand fluorescence, similarly as an anti-fluorescein antibody. Detailed ligand-binding studies and site-directed mutagenesis experiments indicated (i) that the molecular recognition of fluorescein is specific and (ii) that charged residues at the center of the pocket are responsible for tight complex formation. Sequence comparison of the BBP variants directed against fluorescein with the wild-type protein and with further variants that were selected against several other ligands revealed that all of the randomized amino acid positions are variable. Hence, a lipocalin can be used for generating molecular pockets with a diversity of shapes. We term this class of engineered proteins "anticalins." Their one-domain scaffold makes them a promising alternative to antibodies to create a stable receptor protein for a ligand of choice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051566      PMCID: PMC26708          DOI: 10.1073/pnas.96.5.1898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  1.85 A structure of anti-fluorescein 4-4-20 Fab.

Authors:  M Whitlow; A J Howard; J F Wood; E W Voss; K D Hardman
Journal:  Protein Eng       Date:  1995-08

2.  Alternate protein frameworks for molecular recognition.

Authors:  J Ku; P G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

3.  Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein.

Authors:  H L Monaco; M Rizzi; A Coda
Journal:  Science       Date:  1995-05-19       Impact factor: 47.728

4.  A modified medium for efficient electrotransformation of E. coli.

Authors:  W L Tung; K C Chow
Journal:  Trends Genet       Date:  1995-04       Impact factor: 11.639

5.  Structure of the epididymal retinoic acid binding protein at 2.1 A resolution.

Authors:  M E Newcomer
Journal:  Structure       Date:  1993-09-15       Impact factor: 5.006

6.  Pheromone binding to two rodent urinary proteins revealed by X-ray crystallography.

Authors:  Z Böcskei; C R Groom; D R Flower; C E Wright; S E Phillips; A Cavaggioni; J B Findlay; A C North
Journal:  Nature       Date:  1992-11-12       Impact factor: 49.962

7.  Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment in Escherichia coli.

Authors:  A Skerra
Journal:  Gene       Date:  1994-12-30       Impact factor: 3.688

8.  Improved folding of apo-retinol-binding protein in the periplasm of Escherichia coli: positive influences of dsbC coexpression and of an amino acid exchange in the vitamin A binding site.

Authors:  A M Schmidt; I Bloss; A Skerra
Journal:  Protein Eng       Date:  1998-07

9.  Molecular interaction between the Strep-tag affinity peptide and its cognate target, streptavidin.

Authors:  T G Schmidt; J Koepke; R Frank; A Skerra
Journal:  J Mol Biol       Date:  1996-02-09       Impact factor: 5.469

10.  The bilin-binding protein of Pieris brassicae. cDNA sequence and regulation of expression reveal distinct features of this insect pigment protein.

Authors:  F S Schmidt; A Skerra
Journal:  Eur J Biochem       Date:  1994-02-01
View more
  56 in total

1.  Selection of antibodies for intracellular function using a two-hybrid in vivo system.

Authors:  M Visintin; E Tse; H Axelson; T H Rabbitts; A Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  The transfer of transthyretin and receptor-binding properties from the plasma retinol-binding protein to the epididymal retinoic acid-binding protein.

Authors:  Manickavasagam Sundaram; Daan M F van Aalten; John B C Findlay; Asipu Sivaprasadarao
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

3.  Designer proteins in biotechnology. International Titisee Conference on protein design at the crossroads of biotechnology, chemistry and evolution.

Authors:  Hauke Lilie
Journal:  EMBO Rep       Date:  2003-03-14       Impact factor: 8.807

Review 4.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

5.  Resonance assignments for the 21 kDa engineered fluorescein-binding lipocalin FluA.

Authors:  Gaohua Liu; Jeffrey L Mills; Tracy A Hess; Seho Kim; Jack J Skalicky; Dinesh K Sukumaran; Eriks Kupce; Arne Skerra; Thomas Szyperski
Journal:  J Biomol NMR       Date:  2003-10       Impact factor: 2.835

Review 6.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

7.  Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.

Authors:  C Anders Olson; Richard W Roberts
Journal:  Protein Sci       Date:  2007-03       Impact factor: 6.725

8.  Role of conserved residues in structure and stability: tryptophans of human serum retinol-binding protein, a model for the lipocalin superfamily.

Authors:  L H Greene; E D Chrysina; L I Irons; A C Papageorgiou; K R Acharya; K Brew
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

Review 9.  Mechanisms of action of therapeutic antibodies for cancer.

Authors:  J M Redman; E M Hill; D AlDeghaither; L M Weiner
Journal:  Mol Immunol       Date:  2015-04-23       Impact factor: 4.407

10.  NMR structure and dynamics of the engineered fluorescein-binding lipocalin FluA reveal rigidification of beta-barrel and variable loops upon enthalpy-driven ligand binding.

Authors:  Jeffrey L Mills; Gaohua Liu; Arne Skerra; Thomas Szyperski
Journal:  Biochemistry       Date:  2009-08-11       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.